Rankings
▼
Calendar
PRTA FY 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
-92.8% YoY
Gross Profit
$6M
61.8% margin
Operating Income
-$185M
-1905.8% margin
Net Income
-$244M
-2520.6% margin
EPS (Diluted)
$-4.53
Cash Flow
Operating Cash Flow
-$164M
Free Cash Flow
-$164M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$327M
Total Liabilities
$46M
Stockholders' Equity
$280M
Cash & Equivalents
$308M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$135M
-92.8%
Gross Profit
$6M
$135M
-95.6%
Operating Income
-$185M
-$155M
-19.4%
Net Income
-$244M
-$122M
-99.6%
← Q4 2024
All Quarters
Q1 2025 →